fasting plasma glucose


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

fasting plasma glucose (FPG)

a measurement of the concentration of glucose in the plasma after the patient has not eaten for at least 8 hours. See also blood glucose test.

fast·ing plas·ma glu·cose

(FPG) (fast'ing plaz'mă glū'kōs)
Blood levels of the substance measured after patient has not eaten for a given duration; generally assessed by phlebotomy first thing in the morning.
Synonym(s): fasting blood sugar.

fast·ing plas·ma glu·cose

(FPG) (fast'ing plaz'mă glū'kōs)
Blood levels of the substance measured after patient has not eaten for a given duration; generally assessed by phlebotomy first thing in the morning.
References in periodicals archive ?
Additionally, venous fasting plasma glucose levels with diopter changes evaluated a statistically association.
Our study also showed the statistically different profile of Fasting Plasma Glucose (FPG) and HbA1c concentration in NGT, prediabetes and diabetic patients, as shown in Fig 3.
Although testing for diabetes can also be performed with a measurement of fasting plasma glucose or [HbA.
Homeostasis model assessment: insulin resistance and p-cell function from fasting plasma glucose and insulin concentrations in man.
For example, an oral glucose tolerance test with symptoms might be followed up with a fasting plasma glucose," she says.
Compared with those without retinopathy, those with the condition had higher average levels of fasting plasma glucose 10 years prior (130 vs.
The WHO recommends that diabetes be diagnosed if the fasting plasma glucose is [greater than or equal to]7 mmol/l or the 2-hour plasma glucose value following a 75 g oral glucose tolerance test is [greater than or equal to]11.
The drug, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations, it said.
They used the EVA study data, which is a 9 year longitudinal study (1389 male and female subjects, aged 59-71 years), which measured fasting plasma glucose was at baseline, 2, 4 and 9 years.
When added to the common diabetes pill metformin, dapagliflozin cut both levels of both glycosylated hemoglobin--an indication of glucose concentration in the blood--and fasting plasma glucose in patients with type 2 diabetes after 24 weeks, hitting both its main and secondary targets.